These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11073742)

  • 1. Visceral leishmaniasis during childhood in southern Greece.
    Maltezou HC; Siafas C; Mavrikou M; Spyridis P; Stavrinadis C; Karpathios T; Kafetzis DA
    Clin Infect Dis; 2000 Nov; 31(5):1139-43. PubMed ID: 11073742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
    Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug regimens for visceral leishmaniasis in Mediterranean countries.
    Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
    Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
    Shahian M; Alborzi A
    Med Sci Monit; 2009 Jun; 15(6):CR290-3. PubMed ID: 19478699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric visceral leishmaniasis in southern France.
    Minodier P; Piarroux R; Garnier JM; Unal D; Perrimond H; Dumon H
    Pediatr Infect Dis J; 1998 Aug; 17(8):701-4. PubMed ID: 9726344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
    Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
    Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.
    Sundar S; Jha TK; Sindermann H; Junge K; Bachmann P; Berman J
    Pediatr Infect Dis J; 2003 May; 22(5):434-8. PubMed ID: 12792385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis.
    Disch J; Oliveira MC; Orsini M; Rabello A
    Acta Trop; 2004; 92(3):279-83. PubMed ID: 15533299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short report: Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum.
    Antoniou M; Doulgerakis C; Pratlong F; Dedet JP; Tselentis Y
    Am J Trop Med Hyg; 2004 Jul; 71(1):71-2. PubMed ID: 15238692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece.
    Papadopoulou C; Kostoula A; Dimitriou D; Panagiou A; Bobojianni C; Antoniades G
    J Infect; 2005 Jan; 50(1):53-60. PubMed ID: 15603841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visceral leishmaniasis in Alicante. Analysis of 21 cases].
    Portilla Sogorb J; Rosas Gómez de Salazar JC; Casellas Valde JA; Abad Gosálbez A; Monpel Sanjuan A; Palmero Cabezas MF
    Rev Clin Esp; 1990 Jun; 187(2):53-5. PubMed ID: 2244057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.
    Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S
    J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infantile visceral leishmaniasis in Morocco. A review of 67 cases managed at the Rabat Hospital for children (1979-1988)].
    Mikou N; Balafrej A; Benhamou B; Mikou S; Baroudi A
    Ann Pediatr (Paris); 1991 Sep; 38(7):497-502. PubMed ID: 1659303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?
    Caldas AJ; Costa J; Aquino D; Silva AA; Barral-Netto M; Barral A
    Acta Trop; 2006 Mar; 97(3):252-8. PubMed ID: 16420954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.